EyeBiotech raised €57M in a Series A round in Feb 2022. The company is based in London, UK. Investors in the round: Jeito Capital, MRL Ventures Fund, Samsara Biocapital and 1 other. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
